Summa acquires Finnish antibody maker Hytest
Summa Equity has acquired a majority stake in Hytest, a maker of antibodies and antigens used in diagnosing medical conditions.
The
Summa Equity has acquired a majority stake in Hytest, a maker of antibodies and antigens used in diagnosing medical conditions.
The